State of Wisconsin Investment Board’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
RCM
PM
VCM
TCM
State of Wisconsin Investment Board's JANX Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Janux Therapeutics (JANX) stake by 51% in Q1 2026, selling an estimated $268K and leaving 18,911 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2268.
State of Wisconsin Investment Board first reported a position in JANX in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.18M in Q4 2024. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.
- State of Wisconsin Investment Board held 18,911 shares of Janux Therapeutics worth $263K as of Q1 2026.
- State of Wisconsin Investment Board sold 19,576 Janux Therapeutics shares in Q1 2026, an estimated $268K.
- Janux Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2268 holding.
- State of Wisconsin Investment Board first reported a position in Janux Therapeutics in Q1 2022 and has held it in 14 quarters since.
- State of Wisconsin Investment Board's Janux Therapeutics position peaked at $2.18M in Q4 2024.
- 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.